- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05231070
Specialized Palliative Telemedicine for Patients With Advanced Cancer (TeleSPC)
The Effect of Specialized Palliative Telemedicine for Patients With Advanced Cancer at Home
Study Overview
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Geana Kurita, PhD
- Phone Number: +4535 45 71 24
- Email: geana.kurita@regionh.dk
Study Contact Backup
- Name: Camilla Lykke, PhD
- Phone Number: +4535 45 71 24
- Email: camilla.charlotte.lykke.01@regionh.dk
Study Locations
-
-
København Ø.
-
København, København Ø., Denmark, 2100
- Recruiting
- Rigshospitalet
-
Contact:
- Geana Kurita, PHD.
-
Contact:
- Camilla Lykke, PHD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Patient inclusion criteria:
- adults (at least 18 years old)
- solid organ cancer
- no longer receives curativ treatment
- provide written informed consent
- are able to speak and understand Danish Language
- are cognitively able to participate in the study
- have at least one symptom or problem with score ≥ 3 at the EORTC QLQ-C30
Patient exclusion criteria:
- primary brain cancer or central nervous system metastases
- a prognosis of less than six months
- incapable of cooperating in the trial
- already receive SPC
Informal caregiver inclusion criteria:
- adults (at least 18 years old)
- indicated by the patient as the closest informal caregiver
- able to speak and understand danish langues
- provide written informed consent
Informal caregiver exclusion criteria:
- refuse to participate in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: TeleSPC
Patients will be offered regular multidisciplinary video consultations with the SPC team and these patients and their informal caregiver will also be offered a dyadic psychological intervention. Regular multidisciplinary video consultations with multidisciplinary team, involvering cooperation between the section og Palliative medicine and the Department of Oncology, District nurse and the general practitioner. Operationel definition of informal caregiver: Patients will designated the closest person involved in their care (e.g., spouse, son/daughter, other relatives, and friends). |
Multidisciplinary video consultations with the SPC team.
The team is multiprofessional and composed by physician, nurse, psychologist, social worker, physiotherapist and a chaplain, which is in line with the staffing of most SPC teams in Denmark and abroad.
Video consultations will follow the same approach already used in physical consultations at the Section of Palliative Medicine, considering patients' changing needs and providing differentiated treatment and support, with the addition of a psychological intervention for dyadic coping between patient and closest informal caregiver
|
No Intervention: Control
Patients will follow the current practice in the healthcare system (standard care).
Control patients will be offered information to clarify the options available in case of unmet palliative needs.
Patients' informal caregiver will be invited to participate in the study, but no intervention will be offered.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline patient's health-related quality of life at 2 weeks, 4 weeks, 8 weeks, and 6 months
Time Frame: Baseline, 2 weeks, 4 weeks, 8 weeks, and 6 months
|
The European Organisation for Research and Treatment of Cancer Quality of life Questionnaire - Core 30 (EORTC QLQ-C30) to assess several physical and psychosocial aspects of the patient's health-related quality of life.
Scores range from 0 to 100; high values in the functioning and quality of life scales and low values in the symptoms scales indicate better outcomes.
|
Baseline, 2 weeks, 4 weeks, 8 weeks, and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline patients' use of health care system at 6 months
Time Frame: Baseline and 6 months
|
Clinical information collected from patients' records regarding number of hospitalizations, days spent in hospital, and date of death
|
Baseline and 6 months
|
Change from baseline patients and informal caregiver dyadic coping at 4 weeks, 8 weeks, and 6 months
Time Frame: Baseline, 4 weeks, 8 weeks, and 6 months
|
Dyadic Coping inventory to assess how patients and informal caregiver manage stress together concerning decision making and giving support to each other.
Four subscales were selected to evaluate dyadic coping (dyad patient and relative/caregiver) regarding stress communicated by oneself (max.
score 20), stress communication of the partner (max.
score 20), common dyadic coping (max.
score 25), and evaluation of dyadic coping (max score 10).
Higher scores denote greater levels of the constructs measured by each subscale.
|
Baseline, 4 weeks, 8 weeks, and 6 months
|
Change from baseline caregiver burden at 4 weeks, 8 weeks, and 6 months
Time Frame: Baseline, 4 weeks, 8 weeks, and 6 months
|
Zarit Burden Interview to measure subjective burden among caregivers.
Sum of scores ranges from 0 to 88.
A score of 17 or more is considered high burden.
|
Baseline, 4 weeks, 8 weeks, and 6 months
|
Change from baseline informal caregiver health related quality of life at 4 weeks, 8 weeks, and 6 months
Time Frame: Baseline, 4 weeks, 8 weeks, and 6 months
|
RAND 36-Item Short Form Health Survey version 1.0.
Scores range from 0 to 100; a higher score indicates a better result.
|
Baseline, 4 weeks, 8 weeks, and 6 months
|
Healthcare professionals' satisfaction with intervention at 6 months
Time Frame: 6 months
|
Interview with healthcare providers
|
6 months
|
Change from baseline patients' sleep at 2 weeks, 4 weeks, 8 weeks, and 6 months
Time Frame: Baseline, 2 weeks, 4 weeks, 8 weeks, and 6 months
|
Pittsburg Sleep Quality Index to determining the quality and patterns of sleep.
Global score ranges from 0 to 21; 0 indicates no difficult and 21 indicates severe difficlties in all areas.
|
Baseline, 2 weeks, 4 weeks, 8 weeks, and 6 months
|
Change from baseline patients' anxiety at 2 weeks, 4 weeks, 8 weeks, and 6 months
Time Frame: Baseline, 2 weeks, 4 weeks, 8 weeks, and 6 months
|
Hospital anxiety and depression scale.
Scores range from 0 to 21; 0-7 represent non-cases, 8-10 represent doubtful cases, and 11-21 represent definite cases.
|
Baseline, 2 weeks, 4 weeks, 8 weeks, and 6 months
|
Change from baseline patient's depression at 2 weeks, 4 weeks, 8 weeks, and 6 months
Time Frame: Baseline, 2 weeks, 4 weeks, 8 weeks, and 6 months
|
Hospital anxiety and depression scale.
Scores range from 0 to 21; 0-7 represent non-cases, 8-10 represent doubtful cases, and 11-21 represent definite cases.
|
Baseline, 2 weeks, 4 weeks, 8 weeks, and 6 months
|
Patients and informal caregivers' satisfaction with intervention at 6 months
Time Frame: 6 months
|
Patients and informal caregivers will be requested to rate their satisfaction (scale 1-5), and will have the possibility to write any comment
|
6 months
|
Change from baseline informal caregivers' anxiety at 4 weeks, 8 weeks, and 6 months
Time Frame: Baseline, 4 weeks, 8 weeks, and 6 months
|
Patient Health Questionnaires' scales (GAD-7).
Seven items, each of which is scored 0 to 3, providing a 0 to 21 severity score.
|
Baseline, 4 weeks, 8 weeks, and 6 months
|
Change from baseline informal caregivers' depression at 4 weeks, 8 weeks, and 6 months
Time Frame: Baseline, 4 weeks, 8 weeks, and 6 months
|
Patient Health Questionnaires' scales (PHQ).
Nine items, each of which is scored 0 to 3, providing a 0 to 27 severity score.
|
Baseline, 4 weeks, 8 weeks, and 6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Geana P Kurita, PhD, Rigshospitalet, Denmark
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- R315A18018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States